WithdrawnNCT06711640
A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects
Medication studyAges 12–18United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 12 years to 18 years.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: June 2025
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- USWM, LLC (dba US WorldMeds)
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT06711640
- Official title
Show the full official title
A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects
Recruitment & locations
WithdrawnBaltimore
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is USWM, LLC (dba US WorldMeds).
Does this study involve medication?
Yes. The study involves medication, including LUCEMYRA (lofexidine) tablets.
Who can participate?
Listed age limits: 12 years to 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
